|Articles|November 25, 2015

Improving Pharmaceutical Transparency to Patients

There is one way doctors can be more transparent to their patients about their relationships with pharmaceutical companies.

Optimize your practice with the Physicians Practice newsletter, offering management pearls, leadership tips, and business strategies tailored for practice administrators and physicians of any specialty.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Improving Pharmaceutical Transparency to Patients

Related Content

A primary care physician's guide to cyclosporiasis, with Molly O'Shea, M.D.

8 ways to write notes your patients will actually read

Meeting or exceeding patients' expectations

8 factors patients weigh when choosing a treatment

Good lies and bad truths: What's the difference?

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Physicians Practice

6 ways to salvage the patient balances you've already written off

The patient access blind spot, with Mindy Fortson of Experian Health

8 questions to ask before you renew a vendor contract

CMS fraud unit flags 50 Medicaid providers in first 88 days

8 ways to keep seeing patients when your systems go down